FDA Clears Two HCV Drugs for Children FDA Clears Two HCV Drugs for Children

The FDA has approved sofosbuvir (Sovaldi) and the combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C virus (HCV) infection in children aged 12 to 17 years.FDA Approvals
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Alert Source Type: news